Ayako Masaki

1.4k total citations
77 papers, 913 citations indexed

About

Ayako Masaki is a scholar working on Oncology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Ayako Masaki has authored 77 papers receiving a total of 913 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 26 papers in Immunology and 18 papers in Pathology and Forensic Medicine. Recurrent topics in Ayako Masaki's work include T-cell and Retrovirus Studies (24 papers), Vector-Borne Animal Diseases (14 papers) and Lymphoma Diagnosis and Treatment (12 papers). Ayako Masaki is often cited by papers focused on T-cell and Retrovirus Studies (24 papers), Vector-Borne Animal Diseases (14 papers) and Lymphoma Diagnosis and Treatment (12 papers). Ayako Masaki collaborates with scholars based in Japan, Singapore and Germany. Ayako Masaki's co-authors include Hiroshi Inagaki, Shinsuke Iida, Hisashi Takino, Takashi Ishida, Masaki Ri, Shigeru Kusumoto, Asahi Ito, Takayuki Murase, Ryuzo Ueda and Hirokazu Komatsu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and The Journal of Immunology.

In The Last Decade

Ayako Masaki

71 papers receiving 907 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ayako Masaki Japan 17 404 266 238 196 179 77 913
Laurent Frenzel France 14 109 0.3× 62 0.2× 242 1.0× 340 1.7× 56 0.3× 61 899
Hiromu Yano Japan 14 293 0.7× 47 0.2× 325 1.4× 187 1.0× 64 0.4× 46 694
J J Lewis United States 18 671 1.7× 262 1.0× 266 1.1× 269 1.4× 144 0.8× 26 1.4k
Hitoshi Toyoda Japan 10 359 0.9× 99 0.4× 93 0.4× 432 2.2× 36 0.2× 13 812
Kyohei Yamada Japan 14 196 0.5× 14 0.1× 223 0.9× 96 0.5× 213 1.2× 57 528
Mark N. Jabbour Lebanon 18 164 0.4× 90 0.3× 55 0.2× 230 1.2× 64 0.4× 36 670
Megan M. O’Meara United States 17 481 1.2× 22 0.1× 187 0.8× 336 1.7× 255 1.4× 34 952
Margarita Palutke United States 21 296 0.7× 54 0.2× 262 1.1× 172 0.9× 536 3.0× 52 1.1k
Masayuki Kurata Japan 12 341 0.8× 29 0.1× 246 1.0× 152 0.8× 344 1.9× 24 733
Joya Pawade United Kingdom 16 148 0.4× 119 0.4× 97 0.4× 290 1.5× 181 1.0× 43 749

Countries citing papers authored by Ayako Masaki

Since Specialization
Citations

This map shows the geographic impact of Ayako Masaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ayako Masaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ayako Masaki more than expected).

Fields of papers citing papers by Ayako Masaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ayako Masaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ayako Masaki. The network helps show where Ayako Masaki may publish in the future.

Co-authorship network of co-authors of Ayako Masaki

This figure shows the co-authorship network connecting the top 25 collaborators of Ayako Masaki. A scholar is included among the top collaborators of Ayako Masaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ayako Masaki. Ayako Masaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ri, Masaki, Takahiro Nakashima, Arisa Asano, et al.. (2025). Immunosuppressive Effects of Multiple Myeloma‐Derived Extracellular Vesicles Through T Cell Exhaustion. Cancer Science. 116(7). 1861–1870.
2.
3.
Sakamoto, Yuma, Takashi Ishida, Ayako Masaki, et al.. (2022). CCR7 alterations associated with inferior outcome of adult T‐cell leukemia/lymphoma under mogamulizumab treatment. Hematological Oncology. 40(5). 876–884. 7 indexed citations
4.
Sakamoto, Yuma, Takashi Ishida, Ayako Masaki, et al.. (2021). Clinicopathological significance of CD28 overexpression in adult T‐cell leukemia/lymphoma. Cancer Science. 113(1). 349–361. 10 indexed citations
5.
Sakane, Tadashi, Takayuki Murase, Katsuhiro Okuda, et al.. (2021). Expression of cancer testis antigens in thymic epithelial tumors. Pathology International. 71(7). 471–479. 5 indexed citations
6.
Shinjo, Keiko, Miho Suzuki, Keisuke Katsushima, et al.. (2020). Autocrine HGF/c-Met signaling pathway confers aggressiveness in lymph node adult T-cell leukemia/lymphoma. Oncogene. 39(35). 5782–5794. 5 indexed citations
7.
Morita, Maki, Takayuki Murase, Yuma Sakamoto, et al.. (2020). Clinicopathological significance of EGFR pathway gene mutations and CRTC1/3–MAML2 fusions in salivary gland mucoepidermoid carcinoma. Histopathology. 76(7). 1013–1022. 12 indexed citations
8.
Sakamoto, Yuma, Ayako Masaki, Takayuki Murase, et al.. (2020). Immunohistochemistry for CCR4 C‐terminus predicts CCR4 mutations and mogamulizumab efficacy in adult T‐cell leukemia/lymphoma. The Journal of Pathology Clinical Research. 7(1). 52–60. 11 indexed citations
9.
Sakamoto, Yuma, Takashi Ishida, Ayako Masaki, et al.. (2020). Clinical significance of CD28 gene‐related activating alterations in adult T‐cell leukaemia/lymphoma. British Journal of Haematology. 192(2). 281–291. 12 indexed citations
10.
Ishii, Toshihiko, Itaru Urakawa, Ayako Masaki, et al.. (2019). Mogamulizumab Treatment Elicits Autoantibodies Attacking the Skin in Patients with Adult T-Cell Leukemia-Lymphoma. Clinical Cancer Research. 25(14). 4388–4399. 20 indexed citations
11.
Murase, Takayuki, Masaki Ri, Tomoko Narita, et al.. (2019). Immunohistochemistry for identification of CCND1, NSD2, and MAF gene rearrangements in plasma cell myeloma. Cancer Science. 110(8). 2600–2606. 5 indexed citations
12.
Yoshida, Takashi, Masaki Ri, Hirokazu Sasaki, et al.. (2019). Impact of chromosomal abnormalities on the efficacy of lenalidomide plus dexamethasone treatment in patients with relapsed/refractory multiple myeloma. International Journal of Hematology. 110(2). 228–236. 5 indexed citations
13.
Sakane, Tadashi, Takayuki Murase, Katsuhiro Okuda, et al.. (2019). A mutation analysis of the EGFR pathway genes, RAS, EGFR, PIK3CA, AKT1 and BRAF, and TP53 gene in thymic carcinoma and thymoma type A/B3. Histopathology. 75(5). 755–766. 26 indexed citations
14.
Ri, Masaki, Takashi Yoshida, Shiori Kinoshita, et al.. (2019). Expression analysis of two SLAM family receptors, SLAMF2 and SLAMF7, in patients with multiple myeloma. International Journal of Hematology. 110(1). 69–76. 10 indexed citations
15.
Masaki, Ayako, Takashi Ishida, Susumu Suzuki, et al.. (2018). Human T‐cell lymphotropic/leukemia virus type 1 (HTLV‐1) Tax‐specific T‐cell exhaustion in HTLV‐1‐infected individuals. Cancer Science. 109(8). 2383–2390. 23 indexed citations
16.
Murase, Takayuki, Hisashi Takino, Ayako Masaki, et al.. (2018). Postoperative radiotherapy for T1/2N0M0 mucoepidermoid carcinoma positive for CRTC1/3‐MAML2 fusions. Head & Neck. 40(12). 2565–2573. 8 indexed citations
17.
Masaki, Ayako, Yuma Sakamoto, Hisashi Takino, et al.. (2018). Improved clonality detection in Hodgkin lymphoma using a semi‐nested modification of the BIOMED‐2 PCR assay for IGH and IGK rearrangements: A paraffin‐embedded tissue study. Pathology International. 68(5). 287–293. 7 indexed citations
18.
Masaki, Ayako, Takashi Ishida, Yasuhiro Maeda, et al.. (2017). Clinical significance of tryptophan catabolism in Hodgkin lymphoma. Cancer Science. 109(1). 74–83. 22 indexed citations
19.
Ishibashi, Kenichiro, Yôhei Itô, Hisashi Takino, et al.. (2016). Cellular-level characterization of B cells infiltrating pulmonary MALT lymphoma tissues. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 469(5). 575–580. 4 indexed citations
20.
Masaki, Ayako, Takashi Ishida, Yasuhiro Maeda, et al.. (2015). Prognostic Significance of Tryptophan Catabolism in Adult T-cell Leukemia/Lymphoma. Clinical Cancer Research. 21(12). 2830–2839. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laurent Frenzel Breakdown of academic impact, for papers by Hiromu Yano Breakdown of academic impact, for papers by J J Lewis Breakdown of academic impact, for papers by Hitoshi Toyoda Breakdown of academic impact, for papers by Kyohei Yamada Breakdown of academic impact, for papers by Mark N. Jabbour Breakdown of academic impact, for papers by Megan M. O’Meara Breakdown of academic impact, for papers by Margarita Palutke Breakdown of academic impact, for papers by Masayuki Kurata Breakdown of academic impact, for papers by Joya Pawade
Rankless by CCL
2026